Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

Accessible transcript: Animation explaining the NIHR national Patient Recruitment Centres (PRCs) 2022


Published: 15 July 2022

Version: 1

Print this document

Five national Patient Recruitment Centres (PRCs) have been established in the National Health Service.

Launched in 2020, the PRCs are the first family of NIHR-funded research facilities that are 100% dedicated to delivering late-phase, commercial research.

We operate as one, collective network, with a single point of entry and a single costing process for all five sites, making it quicker and easier for you to set up and deliver your research to time and target.
And because we are dedicated to delivering commercial research, we understand how you operate, and what you need.

When you work with us you will benefit from our exceptional clinical research expertise and experience. For example, we can help you to access NHS clinical investigators to lead and conduct your research, across a wide range of therapeutic areas.

We also specialise in harnessing the recruitment potential of local and regional health care communities. So we can help you to extend your recruitment reach beyond specialist hospital clinics. We do this through the use of innovative recruitment strategies and by empowering patients to proactively volunteer to take part in research.

In fact, we are big fans of innovation, and we are happy to explore how we can provide a test bed for new ideas and approaches to clinical trial delivery. This includes exploring the possibilities presented by virtual, hybrid and decentralised trials.

We pride ourselves on prioritising the patient’s experience . We offer a personalised, concierge-style service to all participants throughout their research journey. And our participant feedback shows that 96% would consider taking part in research again at our PRCs.

We are also proud to have been integral to the delivery of COVID-19 vaccine research - such as the Novavax COVID-19 vaccine study, the largest ever double-blind, placebo-controlled study in the UK. Our sites exceeded their recruitment targets and demonstrated their unique ability to rapidly scale up our operations to meet individual trial requirements.

So you see, we are really quite good at what we do.

Get in touch to find out what we can do for you by emailing:
[text on screen: Get in touch:
LinkedIn logo
Twitter logo @NIHR_Industry #NIHRprcs]